Brown Rudnick is partnering with clients to turn good science into good business. We are a leading international law firm advising pharmaceutical, biotechnology, medical device and healthcare companies, as well as investors and strategic partners, across every stage of growth. Combining deep industry knowledge, including former biotech executives and scientists, with sophisticated legal counsel, we help clients navigate intellectual property, financings, licensing transactions, M&A, litigation and other complex business matters. Our integrated U.S. and U.K. teams provide strategic, cross-border guidance, delivering the global capabilities of a leading law firm with the commercial focus and personal attention of a boutique.